We are live on ! Find out more
BCM

Bridgeway Capital Management Portfolio holdings

AUM $4.97B
1-Year Est. Return 44.96%
This Fund
S&P 500
This Quarter Est. Return
-11.29%
1 Year Est. Return
+44.96%
3 Year Est. Return
+114.45%
5 Year Est. Return
+175.29%
10 Year Est. Return
+704.01%
AUM
$4.38B
AUM Growth
-$799M
Cap. Flow
-$109M
Cap. Flow %
-2.49%
Top 10 Hldgs %
5.78%
Holding
1,425
New
121
Increased
257
Reduced
318
Closed
105

Top Buys

Rank Stock Value
1
CRL icon
Charles River Laboratories
CRL
+$21M
2
NUE icon
Nucor
NUE
+$15.4M
3
GIS icon
General Mills
GIS
+$13M
4
DOW icon
Dow Inc
DOW
+$11.2M
5
OXY icon
Occidental Petroleum
OXY
+$10.3M

Top Sells

Rank Stock Value
1
AR icon
Antero Resources
AR
+$17.7M
2
CL icon
Colgate-Palmolive
CL
+$15.8M
3
NSC icon
Norfolk Southern
NSC
+$15.4M
4
WAT icon
Waters Corp
WAT
+$11M
5
NTAP icon
NetApp
NTAP
+$10.6M

Sector Composition

Rank Sector Weight
1 Financials 27.17%
2 Energy 10.91%
3 Industrials 10.83%
4 Consumer Discretionary 9.97%
5 Technology 9.46%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
IMUX icon
1176
Immunic
IMUX
$198M
$131K ﹤0.01%
3,780
-6,000
-61% -$384K
SQZ
1177
DELISTED
SQZ Biotechnologies Company
SQZ
$130K ﹤0.01%
40,800
+12,400
+44% +$44.6K
NPCE icon
1178
Neuropace
NPCE
$474M
$129K ﹤0.01%
+26,148
New +$173K
UAVS icon
1179
AgEagle Aerial Systems
UAVS
$42.1M
$129K ﹤0.01%
200
– –
UFAB
1180
DELISTED
Unique Fabricating, Inc.
UFAB
$129K ﹤0.01%
94,700
– –
KFFB icon
1181
Kentucky First Federal Bancorp
KFFB
$45.4M
$128K ﹤0.01%
+16,000
New +$119K
YCBD icon
1182
cbdMD
YCBD
$5.94M
$128K ﹤0.01%
808
-208
-20% -$49.3K
NH
1183
DELISTED
NantHealth, Inc
NH
$128K ﹤0.01%
20,433
-2,734
-12% -$25.5K
FUSB icon
1184
First US Bancshares
FUSB
$92.2M
$126K ﹤0.01%
11,468
– –
HOOK
1185
DELISTED
HOOKIPA Pharma
HOOK
$126K ﹤0.01%
7,730
-4,150
-35% -$68.7K
TKAT
1186
DELISTED
Takung Art Co., Ltd.
TKAT
$126K ﹤0.01%
76,000
+41,000
+117% +$92.3K
BFI
1187
DELISTED
BurgerFi International, Inc. Common Stock
BFI
$125K ﹤0.01%
38,588
-60,000
-61% -$208K
SGTX
1188
DELISTED
Sigilon Therapeutics, Inc. Common Stock
SGTX
$125K ﹤0.01%
11,538
-3,847
-25% -$51.7K
CALC icon
1189
CalciMedica
CALC
$11.2M
$124K ﹤0.01%
8,143
-857
-10% -$11.7K
TECX
1190
Tectonic Therapeutic
TECX
$570M
$124K ﹤0.01%
11,250
-8,175
-42% -$96.4K
RPID icon
1191
Rapid Micro Biosystems
RPID
$104M
$123K ﹤0.01%
+28,500
New +$133K
CPS icon
1192
Cooper-Standard Automotive
CPS
$491M
$122K ﹤0.01%
24,500
-39,056
-61% -$228K
SABS icon
1193
SAB Biotherapeutics
SABS
$294M
$122K ﹤0.01%
+8,400
New +$176K
SIF icon
1194
SIFCO Industries
SIF
$177M
$121K ﹤0.01%
39,024
– –
AGTC
1195
DELISTED
Applied Genetic Technologies Corporation
AGTC
$120K ﹤0.01%
155,375
-14,525
-9% -$12.9K
UNAM
1196
DELISTED
Unico American Corp
UNAM
$118K ﹤0.01%
54,500
– –
AIM
1197
AIM ImmunoTech
AIM
$7.51M
$118K ﹤0.01%
1,512
-100
-6% -$9.6K
CDTX
1198
DELISTED
Cidara Therapeutics
CDTX
$117K ﹤0.01%
12,000
-500
-4% -$6.18K
JRSH icon
1199
Jerash Holdings
JRSH
$63.9M
$117K ﹤0.01%
+24,900
New +$148K
XELB icon
1200
Xcel Brands
XELB
$6.48M
$117K ﹤0.01%
9,920
– –
46 47
48
49 50

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $4.98B AUM 36.24% 1-Year Est. Return
MA
Marshfield Associates Washington, District of Columbia $4.99B AUM 1.59% 1-Year Est. Return
FFB
First Financial Bankshares Abilene, Texas $4.95B AUM 25.06% 1-Year Est. Return
AM
Atreides Management Boston, Massachusetts $5B AUM 78.34% 1-Year Est. Return
SGM
Skye Global Management West Palm Beach, Florida $5B AUM 11.9% 1-Year Est. Return
PAMP
Polar Asset Management Partners Toronto, Ontario, Canada $5.01B AUM 35.02% 1-Year Est. Return
SMFG
Sumitomo Mitsui Financial Group Tokyo, Japan $4.94B AUM 1.39% 1-Year Est. Return
SIA
Sit Investment Associates Minneapolis, Minnesota $4.93B AUM 12.22% 1-Year Est. Return

Bridgeway Capital Management's Q2 2022 Portfolio in Review

As of Q2 2022, Bridgeway Capital Management held 1,425 positions worth $4.38B, down 15% from $5.17B the previous quarter. Its ten largest holdings account for 5.8% of the portfolio.

Bridgeway Capital Management's Q2 2022 filing shows 121 new, 257 increased, 318 reduced and 105 closed positions. Its largest new stake was Charles River Laboratories: 86,100 shares worth $18.4M. The largest sale was Antero Resources, an estimated $17.7M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 25% a quarter earlier, followed by Energy and Industrials.

  • Bridgeway Capital Management's largest Q2 2022 buy was Charles River Laboratories: 86,100 shares worth $18.4M.
  • Bridgeway Capital Management added most to Nucor in Q2 2022, an estimated $15.4M increase.
  • Bridgeway Capital Management's biggest Q2 2022 reduction was Antero Resources, cutting an estimated $17.7M.
  • Bridgeway Capital Management fully exited Colgate-Palmolive in Q2 2022, selling an estimated $15.8M.
  • Bridgeway Capital Management's ten largest holdings make up 5.8% of its $4.38B portfolio in Q2 2022.
  • Bridgeway Capital Management opened 121 new positions and closed 105 in Q2 2022.
  • Bridgeway Capital Management's portfolio value fell 15% quarter-over-quarter to $4.38B.

Based on Bridgeway Capital Management's 13F filing for Q2 2022, filed 15 Aug 2022.